These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35106431)

  • 1. Direct oral anticoagulants-Remove versus Taipan snake venom time for detection of a lupus anticoagulant in patients taking oral direct factor Xa inhibitors.
    White D; Moore GW; Besser M; MacDonald S; Thomas W
    Res Pract Thromb Haemost; 2022 Jan; 6(1):e12648. PubMed ID: 35106431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International multicenter, multiplatform study to validate Taipan snake venom time as a lupus anticoagulant screening test with ecarin time as the confirmatory test: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
    Moore GW; Jones PO; Platton S; Hussain N; White D; Thomas W; Rigano J; Pouplard C; Gray E; Devreese KMJ
    J Thromb Haemost; 2021 Dec; 19(12):3177-3192. PubMed ID: 34192404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taipan snake venom time has high sensitivity for lupus anticoagulants in non-anticoagulated, triple positive antiphospholipid syndrome patients.
    Moore GW; Platton S; Yartey N; Foxton E; White D; MacDonald SG
    Int J Lab Hematol; 2024 Jun; 46(3):538-545. PubMed ID: 38303489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taipan snake venom time coupled with ecarin time enhances lupus anticoagulant detection in nonanticoagulated patients.
    Moore GW; Culhane AP; Maloney JC; Archer RA; Breen KA; Hunt BJ
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):477-80. PubMed ID: 26656903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining Taipan snake venom time/Ecarin time screening with the mixing studies of conventional assays increases detection rates of lupus anticoagulants in orally anticoagulated patients.
    Moore GW
    Thromb J; 2007 Sep; 5():12. PubMed ID: 17822554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants.
    Ząbczyk M; Kopytek M; Natorska J; Undas A
    Clin Chem Lab Med; 2019 Aug; 57(9):1374-1381. PubMed ID: 30763261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance Characteristics of DOAC-Remove for Neutralization of the Effects of Apixaban and Rivaroxaban in Lupus Anticoagulant Assays.
    Skaugen JM; Sayre C; Hassett AC; Chibisov I; Bontempo F; Meyer MP; Seheult JN
    Am J Clin Pathol; 2022 Mar; 157(3):457-469. PubMed ID: 34698336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A diagnostic solution for haemostasis laboratories for patients taking direct oral anticoagulants using DOAC-Remove.
    Cox-Morton S; MacDonald S; Thomas W
    Br J Haematol; 2019 Nov; 187(3):377-385. PubMed ID: 31290570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newly developed dilute Russell's viper venom reagents for lupus anticoagulant detection with improved specificity.
    Moore GW; Peyrafitte M; Dunois C; Amiral J
    Lupus; 2018 Jan; 27(1):95-104. PubMed ID: 28549386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants.
    Jourdi G; Delrue M; Stepanian A; Valaize J; Foulon-Pinto G; Demagny J; Duchemin J; Nedelec-Gac F; Darnige L; Curis E; Delavenne X; Gaussem P; Siguret V; Gouin-Thibault I
    Thromb Res; 2019 Dec; 184():86-91. PubMed ID: 31710863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus anticoagulant diagnosis in patients receiving direct oral FXa inhibitors at trough levels: A real-life study.
    Gay J; Duchemin J; Imarazene M; Fontenay M; Jourdi G
    Int J Lab Hematol; 2019 Dec; 41(6):738-744. PubMed ID: 31487115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Taipan snake venom time: a new test for lupus anticoagulant.
    Rooney AM; McNally T; Mackie IJ; Machin SJ
    J Clin Pathol; 1994 Jun; 47(6):497-501. PubMed ID: 8063928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of the Taipan snake venom assay in assessing lupus anticoagulant status in individuals receiving or not receiving an oral vitamin K antagonist.
    Parmar K; Lefkou E; Doughty H; Connor P; Hunt BJ
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):271-5. PubMed ID: 19530340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lupus Anticoagulant Testing: Taipan Snake Venom Time with Ecarin Time as Confirmatory Test.
    Moore GW
    Methods Mol Biol; 2023; 2663():263-274. PubMed ID: 37204716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effect of the anti-Xa direct oral anticoagulants apixaban, edoxaban, and rivaroxaban on coagulation assays.
    Gosselin R; Grant RP; Adcock DM
    Int J Lab Hematol; 2016 Oct; 38(5):505-13. PubMed ID: 27265752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolving DOAC interference on aPTT, PT, and lupus anticoagulant testing by the use of activated carbon.
    Frans G; Meeus P; Bailleul E
    J Thromb Haemost; 2019 Aug; 17(8):1354-1362. PubMed ID: 31102433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple method for removing DOACs from plasma samples.
    Exner T; Michalopoulos N; Pearce J; Xavier R; Ahuja M
    Thromb Res; 2018 Mar; 163():117-122. PubMed ID: 29407622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative assays to dRVVT and aPTT for lupus anticoagulant detection.
    Moore GW
    Am J Hematol; 2020 Aug; 95(8):992-998. PubMed ID: 32311119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome.
    Arachchillage DR; Mackie IJ; Efthymiou M; Isenberg DA; Machin SJ; Cohen H
    J Thromb Haemost; 2015 Jul; 13(7):1264-73. PubMed ID: 25850997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting.
    Antovic A; Norberg EM; Berndtsson M; Rasmuson A; Malmström RE; Skeppholm M; Antovic J
    Thromb Haemost; 2017 Aug; 117(9):1700-1704. PubMed ID: 28640321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.